This HTML5 document contains 196 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.3748/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35010409
rdf:type
wikibase:Item
schema:description
article científic mokslinis straipsnis artigo científico (publicado na 2005) artigo científico (publicado na 2005) 2005年论文 artikull shkencor wissenschaftlicher Artikel บทความทางวิทยาศาสตร์ 2005年論文 2005年論文 tudományos cikk наукова стаття, опублікована в березні 2005 teaduslik artikkel 2005 թուականի Մարտին հրատարակուած գիտական յօդուած 2005年论文 artigo científico 2005년 논문 مقالة علمية ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2005年の論文 2005年論文 scienca artikolo 2005年論文 научная статья 2005年论文 naučni članak bilimsel makale tieteellinen artikkeli artículu científicu espublizáu en 2005 article scientifique (publié 2005) мақолаи илмӣ bài báo khoa học vitskapeleg artikkel articol științific 2005年論文 artykuł naukowy artikulong pang-agham artículo científico publicado en 2005 2005 թվականի մարտին հրատարակված գիտական հոդված article scientific videnskabelig artikel (udgivet 2005) 2005年论文 vitenskapelig artikkel scientific article vetenskaplig artikel vědecký článek επιστημονικό άρθρο wetenschappelijk artikel vedecký článok مقالهٔ علمی научни чланак სამეცნიერო სტატია 2005年论文 articolo scientifico سائنسی مضمون научна статия 2005 nî lūn-bûn 2005年论文 מאמר מדעי мақолаи илмӣ научни чланак
p:P577
wds:Q35010409-D207AA33-FE51-4ECC-829F-292DA78C8B20
wdt:P577
2005-03-01T00:00:00Z
p:P407
wds:Q35010409-3157267F-55C5-4465-8967-6A7C621AF982
wdt:P407
wd:Q1860
p:P2860
wds:Q35010409-04BFD89D-1156-4AD7-AE06-9ED79F4D0E4F wds:Q35010409-05020D72-88CE-4AC3-ACCD-6F2C6A224BE2 wds:Q35010409-0A746383-F74A-4271-B043-9BF243E6AB13 wds:Q35010409-117F6553-1366-4089-901B-2CB943B79E5E wds:Q35010409-17A0B7A8-5372-46BE-BC7A-154AE1C1ACE5 wds:Q35010409-186C9F2C-EE6D-4DBE-B679-78D708559DC1 wds:Q35010409-1B62F5C6-547F-46B7-84B2-418D92CFC2D4 wds:Q35010409-1BC23025-BA2D-4CDF-B6B3-CBDD709CF3B0 wds:Q35010409-1F45944E-5431-4A1D-9139-6C988C3E4FE0 wds:Q35010409-235005B7-AE26-47A7-89E4-658684F7F588 wds:Q35010409-3446500C-640E-46AD-AD43-2E4719384C10 wds:Q35010409-3925ED0F-1E57-494D-8957-24FC5158FDE9 wds:Q35010409-3A54FF45-53D7-4788-BD1A-43964FDC39C7 wds:Q35010409-3FBD61BA-1F2E-4F3D-B235-14033FD59341 wds:Q35010409-40AE4D70-51FE-4A8C-852B-CBF1A465FD9C wds:Q35010409-541CC790-1E5B-4F9A-8488-6B3C36A0609E wds:Q35010409-5EF6FB30-AA5A-4E95-A241-84C7E2210923 wds:Q35010409-6A8A5B16-944A-4BB8-B3CD-94DE10444F02 wds:Q35010409-6AD315FA-8943-4825-81F7-9222A9EF7B60 wds:Q35010409-75F8AC43-E035-4FD8-8F80-CFE4235495D6 wds:Q35010409-76685EA9-6167-44CB-9196-DDCDE85016CC wds:Q35010409-7DE903B3-D465-4AEA-AFFD-610934EDAD0A wds:Q35010409-7F97FD12-ED39-4740-AF12-5D0C0EE5E28D wds:Q35010409-84B4D79C-4933-4AD7-A439-41AF8DEA39B9 wds:Q35010409-84BB7A95-6BA1-43C5-8524-E51723E918B3 wds:Q35010409-84E5EBA5-B2FF-4CD1-AE20-3CD3D1001E18 wds:Q35010409-8FDABF47-FC48-4C15-87D0-ECACAD1CE522 wds:Q35010409-9158A687-F9BE-4ADE-A9DE-C1C33411181C wds:Q35010409-A5A99BAD-0CB0-4B0D-876A-586601105A0F wds:Q35010409-ABAB42D1-9F59-43FF-945A-75543445ABE0 wds:Q35010409-B70D437C-86F3-4752-9E8D-FF6C0D77CF23 wds:Q35010409-B8FCF25B-93BA-4309-BFC6-FA7FD222958D wds:Q35010409-B9E947B2-85C5-420D-8242-5E387A69AF0F wds:Q35010409-C7506A4E-2B01-48DA-80FC-F1AC48C2B620 wds:Q35010409-CC257944-6E03-4121-A987-F93D74091E9C wds:Q35010409-CDA66758-D0B1-4AF5-A043-00723BF85149 wds:Q35010409-D894D8AD-3C2B-4A8E-A119-2F43E69F3DF3 wds:Q35010409-DEDF69D9-2226-4584-9DBD-1F8C1D9EC103 wds:Q35010409-DF493A80-0DBE-47E3-9739-EA0E5B0A7414 wds:Q35010409-E86A8221-5B3D-433D-BB13-DC603739E21E wds:Q35010409-EABD4804-A0E0-4F64-AEBE-F658F60CDD1F wds:Q35010409-EC37923D-BACB-4698-BBEF-211BD336AFEC wds:Q35010409-EFCB6ECD-106D-429D-9FA0-08688A5C4326 wds:Q35010409-EFF302FF-9F97-49E5-AF31-1F4A52C6A6E7 wds:Q35010409-02F1FB4E-7E58-4108-A1AB-BCB89ABF1E2F
wdt:P2860
wd:Q40815955 wd:Q79217658 wd:Q47330105 wd:Q44689809 wd:Q33289370 wd:Q40536152 wd:Q74595692 wd:Q34546021 wd:Q73849844 wd:Q35194986 wd:Q40585893 wd:Q38450356 wd:Q33906145 wd:Q42915741 wd:Q43565451 wd:Q77407102 wd:Q79342674 wd:Q53392717 wd:Q77449367 wd:Q39358305 wd:Q73907326 wd:Q28143276 wd:Q78513898 wd:Q47910292 wd:Q79340545 wd:Q43512567 wd:Q55517832 wd:Q73841954 wd:Q28177568 wd:Q38348323 wd:Q79103460 wd:Q40780006 wd:Q47395940 wd:Q43867959 wd:Q34269663 wd:Q35831548 wd:Q35195972 wd:Q34527230 wd:Q47802752 wd:Q44509492 wd:Q40925555 wd:Q42830140 wd:Q79288978 wd:Q34512068 wd:Q73235441
p:P2093
wds:Q35010409-8931E870-0394-4D1A-AE14-AF5D6C5B0AA4 wds:Q35010409-3A39ACED-0438-4894-AE64-03B768D99E1B wds:Q35010409-68B1B6BC-FD0C-49D8-B1B2-735A1682F673 wds:Q35010409-D538F6AB-69FD-4CAA-BC1D-3022544127AE wds:Q35010409-F0E5AB1C-0949-4927-9A38-F1D5DE66086D wds:Q35010409-CAA8E2D5-C2B0-44A0-A85B-4F3369CCB03C
wdt:P2093
De-Rong Xie Hong-Hao Li Hai-Gang Li Hong Zeng Xi-Ming Shen Yun-Jie Zeng
rdfs:label
Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma
skos:prefLabel
Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma
schema:name
Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma
p:P1476
wds:Q35010409-1CC4435C-14AA-4711-930D-8CDFF9EA7357
wdt:P1476
Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma
p:P304
wds:Q35010409-C63046BC-1EBA-444F-B93E-2ED720808004
wdt:P304
1445-1451
p:P31
wds:Q35010409-3FED6675-FDD4-46DB-B8D1-9FBE50CA4797
wdt:P31
wd:Q13442814
p:P698
wds:Q35010409-691993E2-B21F-4766-9818-237CED5AEC93
wdtn:P698
n11:15770719
wdt:P698
15770719
p:P1433
wds:Q35010409-4053BC9F-1BA0-48E7-B1D6-C9D509DB636B
wdt:P1433
wd:Q15708885
p:P433
wds:Q35010409-166580EC-237B-46C8-B799-290723FB8E28
p:P478
wds:Q35010409-D495EA15-A80C-468F-823F-265F09BF7280
wdt:P433
10
wdt:P478
11
p:P356
wds:Q35010409-91E7B35F-8C6D-4271-B069-06CA2EDA6B0E
wdtn:P356
n8:WJG.V11.I10.1445
wdt:P356
10.3748/WJG.V11.I10.1445
p:P5875
wds:Q35010409-693B0ED1-605E-4458-B998-71BE6AD5D96B
wdt:P5875
7963561
p:P932
wds:Q35010409-4B447EE3-3964-4B06-8DA7-7D83845C80C5
wdt:P932
4305685